Literature DB >> 16475753

Target volume dose considerations in proton beam treatment planning for lung tumors.

Martijn Engelsman1, Hanne M Kooy.   

Abstract

We performed a treatment planning study in order to gather basic insight in the effect of setup errors and breathing motion on the cumulative proton dose to a lung tumor. We used a simplified geometry that simulates a 50 mm diameter gross tumor volume (GTV) located centrally inside lung tissue. The GTV was expanded with a uniform 5 mm margin into a clinical target volume (CTV) and into a variety of planning target volume (PTV's). Proton beam apertures were designed to conform the prescribed dose laterally to the PTV while the range compensator was designed to provide distal coverage of the CTV. Different smearing distances were applied to the range compensators, and the cumulative dose in the CTV was evaluated for different combinations of breathing motion and systematic setup errors. Evaluation parameters were the dose to 99% of the CTV (D99) and the equivalent uniform dose (EUD), with a surviving fraction at 2 Gy of SF2 = 0.5. For a single proton field designed to a 15 mm expansion of the CTV and without smearing applied to the range compensator, D99 of the CTV reduced from 96% for no tumor displacement to 41% and 13% for systematic setup errors of 5 and 10 mm, respectively. For a representative clinical combination, of 5 mm systematic error and 10 mm breathing amplitude, the EUD of the CTV was about 40 Gy (prescribed dose 70 Gy) regardless the CTV to PTV margin, and without smearing. Smearing the range compensator increases the dose to the CTV substantially with a lateral margin and smearing distance of 7.5 mm providing ample tumor coverage. In this latter case, D99 of the target volume increased to 87% for a single field treatment plan. Smearing does, however, lead to an increase in dose to normal tissues distal to the clinical target volume. Next to countering geometric mismatches due to patient setup, smearing can also be used to counter the detrimental effects of breathing motion on the dose to the clinical target volume. We show that the lateral margin and smearing distance can be substantially smaller than the maximum tumor displacement due to setup errors and patient breathing, as measured by the D99 and the EUD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16475753     DOI: 10.1118/1.2126187

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  20 in total

1.  Investigation of an implantable dosimeter for single-point water equivalent path length verification in proton therapy.

Authors:  Hsiao-Ming Lu; Greg Mann; Ethan Cascio
Journal:  Med Phys       Date:  2010-11       Impact factor: 4.071

2.  Proton radiotherapy: the biological effect of treating alternating subsets of fields for different treatment fractions.

Authors:  Martijn Engelsman; Thomas F DeLaney; Theodore S Hong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-02       Impact factor: 7.038

3.  A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties.

Authors:  Peter C Park; X Ronald Zhu; Andrew K Lee; Narayan Sahoo; Adam D Melancon; Lifei Zhang; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-06-22       Impact factor: 7.038

4.  Proton SBRT for medically inoperable stage I NSCLC.

Authors:  Kenneth D Westover; Joao Seco; Judith A Adams; Michael Lanuti; Noah C Choi; Martijn Engelsman; Henning Willers
Journal:  J Thorac Oncol       Date:  2012-06       Impact factor: 15.609

5.  Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.

Authors:  Pablo Botas; Clemens Grassberger; Gregory Sharp; Harald Paganetti
Journal:  Phys Med Biol       Date:  2018-01-30       Impact factor: 3.609

6.  Statistical assessment of proton treatment plans under setup and range uncertainties.

Authors:  Peter C Park; Joey P Cheung; X Ronald Zhu; Andrew K Lee; Narayan Sahoo; Susan L Tucker; Wei Liu; Heng Li; Radhe Mohan; Laurence E Court; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-05-18       Impact factor: 7.038

7.  Effects of interfractional motion and anatomic changes on proton therapy dose distribution in lung cancer.

Authors:  Zhouguang Hui; Xiaodong Zhang; George Starkschall; Yupeng Li; Radhe Mohan; Ritsuko Komaki; James D Cox; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-05-15       Impact factor: 7.038

8.  Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients.

Authors:  Alfredo E Echeverria; Matthew McCurdy; Richard Castillo; Vincent Bernard; Natalia Velez Ramos; William Buckley; Edward Castillo; Ping Liu; Josue Martinez; Thomas Guerrero
Journal:  Radiother Oncol       Date:  2012-11-02       Impact factor: 6.280

9.  Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers.

Authors:  Wei Liu; Steven J Frank; Xiaoqiang Li; Yupeng Li; Peter C Park; Lei Dong; X Ronald Zhu; Radhe Mohan
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

10.  Fast range-corrected proton dose approximation method using prior dose distribution.

Authors:  Peter C Park; Joey Cheung; X Ronald Zhu; Narayan Sahoo; Laurence Court; Lei Dong
Journal:  Phys Med Biol       Date:  2012-05-16       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.